International Clinical Trial: A Phase II, Single-Arm Clinical Study of Irinotecan Liposome (II) in Combination with Cetuximab for the Treatment of Third-Line or Later Advanced Metastatic Colorectal Cancer

Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118261) titled 'A Phase II, Single-Arm Clinical Study of Irinotecan Liposome (II) in Combination with Cetuximab for the Treatment of Third-Line or Later Advanced Metastatic Colorectal Cancer' on Feb. 3.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Shenzhen Second People's Hospital

Condition: Patients with unresectable advanced metastatic colorectal cancer (MSS or MSI-L/pMMR, RAS and BRAF wild-type) who have failed at least two lines of prior chemotherapy.

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-02-10

Target Sample Size: Experimental group:87;

Countrie...